Working with a registered dietitian familiar with GLP-1 therapy helps you identify trigger foods and optimize nutrient absorption in your altered digestive system
However, some studies suggest that, after about 1 year, a number of people who stop taking a GLP-1 may regain as much as 60% of the weight they had lost while on the drug
doi: 10.1038/nrgastro.2017.101 190
The FDA approved a different formulation of Semaglutide GLP-1, marketed as Wegovy, which is explicitly designed for chronic weight management in adults with obesity or those who are overweight with at least one weight-related condition, such as high blood pressure or type 2 diabetes
In practice, coverage is rare for several reasons: Adult GH deficiency requires specific lab criteria (low IGF-1, stimulation testing) that most patients dont meet Compounded medications are typically not insurance-eligible regardless of indication Off-label use for anti-aging, energy, or general wellness is never covered HSA and FSA funds are sometimes eligible with a letter of medical necessity from the prescribing clinician
She left the Oregon Project in 2011, after seven years